🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 7 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/10/2019 36,89 38,75 35,60 35,95 -1,78% 8,54% 3.643.900
17/10/2019 34,97 37,33 34,51 36,60 +6,06% 8,06% 2.397.300
16/10/2019 34,25 34,74 34,04 34,51 +0,48% 2,03% 952.100
15/10/2019 33,25 34,39 33,22 34,35 +4,14% 3,53% 825.700
14/10/2019 32,51 33,50 32,06 32,98 +1,32% 4,44% 851.400
11/10/2019 32,29 32,86 31,83 32,55 +1,72% 3,19% 1.071.400
10/10/2019 31,28 32,12 31,15 32,00 +2,47% 3,11% 922.200
09/10/2019 32,13 32,44 31,09 31,23 -0,79% 4,20% 806.600
08/10/2019 31,51 32,22 31,15 31,48 -1,10% 3,41% 1.218.000
07/10/2019 30,63 32,03 30,43 31,83 +4,02% 5,22% 1.244.900
04/10/2019 29,61 30,68 29,55 30,60 +2,27% 3,82% 898.500
03/10/2019 29,30 29,94 28,26 29,92 +3,46% 5,73% 883.800
02/10/2019 27,85 29,45 27,12 28,92 +2,77% 8,38% 1.350.900
01/10/2019 28,10 28,87 27,50 28,14 -0,14% 4,88% 1.405.800
30/09/2019 26,01 28,53 25,97 28,18 +4,53% 9,86% 1.378.700
27/09/2019 27,19 27,71 26,34 26,96 -1,14% 5,06% 1.205.900
26/09/2019 28,24 28,63 27,10 27,27 -3,50% 5,40% 959.800
25/09/2019 28,00 28,66 27,58 28,26 +0,64% 3,86% 1.221.800
24/09/2019 29,00 29,10 27,45 28,08 -2,77% 5,69% 1.814.600
23/09/2019 29,10 29,10 28,63 28,88 +0,07% 1,62% 1.285.900
20/09/2019 29,09 29,53 28,32 28,86 -0,79% 4,16% 2.591.600
19/09/2019 29,31 29,69 28,95 29,09 -0,65% 2,52% 1.534.700
18/09/2019 29,67 29,67 28,45 29,28 -0,88% 4,11% 1.677.900
17/09/2019 29,66 30,43 29,14 29,54 +0,34% 4,35% 1.000.700
16/09/2019 31,00 31,46 28,75 29,44 -1,70% 8,74% 1.631.600
13/09/2019 30,01 30,46 29,61 29,95 -0,63% 2,83% 847.000
12/09/2019 30,78 31,20 29,44 30,14 -2,43% 5,72% 1.351.800
11/09/2019 28,78 30,92 28,78 30,89 +7,56% 7,44% 1.814.100
10/09/2019 28,42 28,95 27,81 28,72 +0,07% 4,01% 1.428.700
09/09/2019 31,45 31,59 27,63 28,70 -8,92% 12,59% 2.698.600